Clinical Trial Detail

NCT ID NCT03110354
Title DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Inc.
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

Therapies

DS-3201b

Age Groups: adult senior

No variant requirements are available.